Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Wall Street Thinks This Top 100 Robinhood Stock Could Skyrocket by 217%

TheMotleyFool

0 0

Wall Street Thinks This Top 100 Robinhood Stock Could Skyrocket by 217%: https://g.foolcdn.com/editorial/images/703160/person-getting-vaccinated.jpg

Vaccine maker Ocugen (NASDAQ: OCGN) has had a tumultuous past 18 months on the stock market. The company's shares soared as it sought to make good on its intentions to enter the COVID-19 vaccine space, but with the delays it has encountered in this area, investors have largely given up.

Except those on Robinhood, the popular trading app. Ocugen features on the list of the 100 most held stocks on the platform. Perhaps that's because, on average, Wall Street analysts have set a price target of $5.83 for the stock (according to Yahoo! Finance), which represents a substantial 217% upside from its current levels.

So is this penny stock worth investing in?

Source Fool.com

Like: 0

OCGN

Share